Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Gilbert

Showing results (91-100 of 453) with videos related to

Pageof 46
Sort By:
Neuro-Oncology Practice|December 29, 2025
Clinical outcome assessment trends in neuro-oncology trialsYeonju Kim, Mark R Gilbert, Terri S Armstrong, et al.
Journal of the National Cancer Institute|September 26, 2024
Disparities in the availability of and access to neuro-oncology trial-supporting infrastructure in the United StatesYeonju Kim, Terri S Armstrong, Mark R Gilbert, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|August 27, 2015
Early T Stage Salivary Duct Carcinoma: Outcomes and Implications for Patient CounselingNicole C Schmitt, Arun Sharma, Mark R Gilbert, et al.
Frontiers in Cellular Neuroscience|October 31, 2017
Targeting WNT Signaling for Multifaceted Glioblastoma TherapyMatthew McCord, Yoh-Suke Mukouyama, Mark R Gilbert, et al.
Neuro-Oncology|February 9, 2023
A critical analysis of neuro-oncology clinical trialsYeonju Kim, Terri S Armstrong, Mark R Gilbert, et al.
Cancer|September 30, 2016
Clinical presentation and outcomes for adult ependymoma patientsAlvina A Acquaye, Elizabeth Vera, Mark R Gilbert, et al.
Neuro-Oncology|February 7, 2012
Management of treatment-associated toxicites of anti-angiogenic therapy in patients with brain tumorsTerri S Armstrong, Patrick Y Wen, Mark R Gilbert, et al.
Journal of Geriatric Oncology|September 16, 2019
Failure to complete standard radiation therapy in glioblastoma patients: Patterns from a national database with implications for survival and therapeutic decision making in older glioblastoma patientsEric Burton, Mehran Yusuf, Mark R Gilbert, et al.
Cancer Investigation|June 18, 2004
ANNA-2: an antibody associated with paraneoplastic opsoclonus in a patient with large-cell carcinoma of the lung with neuroendocrine features--correlation of clinical improvement with tumor responseRodrigo Erlich, Candis Morrison, Bong Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2016
Bayesian Optimal Interval Design: A Simple and Well-Performing Design for Phase I Oncology TrialsYing Yuan, Kenneth R Hess, Susan G Hilsenbeck, et al.
Pageof 46

Showing results (91-100 of 453) with videos related to

Sort By:
Pageof 46
Neuro-Oncology Practice|December 29, 2025
Clinical outcome assessment trends in neuro-oncology trialsYeonju Kim, Mark R Gilbert, Terri S Armstrong, et al.
Journal of the National Cancer Institute|September 26, 2024
Disparities in the availability of and access to neuro-oncology trial-supporting infrastructure in the United StatesYeonju Kim, Terri S Armstrong, Mark R Gilbert, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|August 27, 2015
Early T Stage Salivary Duct Carcinoma: Outcomes and Implications for Patient CounselingNicole C Schmitt, Arun Sharma, Mark R Gilbert, et al.
Frontiers in Cellular Neuroscience|October 31, 2017
Targeting WNT Signaling for Multifaceted Glioblastoma TherapyMatthew McCord, Yoh-Suke Mukouyama, Mark R Gilbert, et al.
Neuro-Oncology|February 9, 2023
A critical analysis of neuro-oncology clinical trialsYeonju Kim, Terri S Armstrong, Mark R Gilbert, et al.
Cancer|September 30, 2016
Clinical presentation and outcomes for adult ependymoma patientsAlvina A Acquaye, Elizabeth Vera, Mark R Gilbert, et al.
Neuro-Oncology|February 7, 2012
Management of treatment-associated toxicites of anti-angiogenic therapy in patients with brain tumorsTerri S Armstrong, Patrick Y Wen, Mark R Gilbert, et al.
Journal of Geriatric Oncology|September 16, 2019
Failure to complete standard radiation therapy in glioblastoma patients: Patterns from a national database with implications for survival and therapeutic decision making in older glioblastoma patientsEric Burton, Mehran Yusuf, Mark R Gilbert, et al.
Cancer Investigation|June 18, 2004
ANNA-2: an antibody associated with paraneoplastic opsoclonus in a patient with large-cell carcinoma of the lung with neuroendocrine features--correlation of clinical improvement with tumor responseRodrigo Erlich, Candis Morrison, Bong Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2016
Bayesian Optimal Interval Design: A Simple and Well-Performing Design for Phase I Oncology TrialsYing Yuan, Kenneth R Hess, Susan G Hilsenbeck, et al.
Pageof 46